Medac Pharma, Inc.
- FDA Approves Rasuvo (methotrexate) Injection - July 14, 2014
- Medac Pharma, Inc. Secures FDA Acceptance of a New Drug Application (NDA) for Methotrexate-Containing Autopen - January 27, 2014
Drugs Associated with Medac Pharma, Inc.
Medac Pharma, Inc. manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Generic name: methotrexate
Drug class: antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants
|For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).|